Effect of Yoga on Psychological Aspect and Quality of Life in Premenstrual Syndrome
1 other identifier
interventional
46
1 country
1
Brief Summary
This study will be carried out to evaluate the effect of yoga on psychological aspect and quality of life in premenstrual syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 29, 2024
CompletedFirst Posted
Study publicly available on registry
October 30, 2024
CompletedStudy Start
First participant enrolled
November 2, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedJuly 15, 2025
October 1, 2024
8 months
October 29, 2024
July 11, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
Assessment of premenstrual symptoms
It will be assessed using daily record of severity of problems (DRSP). It was used to capture premenstrual symptoms. DRSP contained two parts: symptoms related to menstruation (21 items) and their impairment in daily life (3 items). The symptoms included depression, hopelessness, feelings of worthlessness, increased sleeping, trouble sleeping, feeling overwhelmed, breast tenderness, breast swelling, headache, joint or muscle pain, anger, conflicts or problems with people, anxiety, mood swings, sensitivity to rejection, decreased interest, difficulty concentrating, fatigue, increased appetite, craving specific foods, and feeling out of control All items were rated from 1 ("not at all") to 6 ("extreme"). The higher the score, the more severe the premenstrual symptoms.
8 weeks
Assessment of anxiety
The spielberger state trait anxiety inventory will be used to assess anxiety for all participants. It is a 40-item self-report measure of anxiety using a 4-point Likert-type scale for each item. It has two scales: State anxiety, i.e. how one feels at the moment; and Trait anxiety, i.e. how one generally feels. Both scales consist of 20 items. its score is ranged from 20-80 on both its two subscales. from 20-37 means no or low anxiety, 38-44 means moderate anxiety and 45-80 means severe anxiety.
8 weeks
Assessment of depression:
It will be assessed using Beck depression inventory. It is a 21-item, self-rated scale that evaluates key symptoms of depression including mood, pessimism, sense of failure, self-dissatisfaction, guilt, punishment, self-dislike, self-accusation, suicidal ideas, crying, irritability, social withdrawal, indecisiveness, body image change, work difficulty, insomnia, fatigability, loss of appetite, weight loss, somatic preoccupation, and loss of libido. its score is ranged from 0-63 and the lowest is zero.
8 weeks
Assessment of Quality of life
the SF-36 questionnaire will be used to assess quality of life for all participants. It consists of 36 questions. The SF-36 assesses eight dimensions that include: physical function, role limitations due to physical health problems, bodily pain, general health, vitality, social functioning, role limitation due to emotional problems, and mental health. the score is ranged from 0-100. 1 is for the worse health and 100 for the ideal health.
8 weeks
Assessment of stress level
A blood sample will be taken from each woman in the two groups at pre-treatment and post-treatment to measure cortisol levels at 8 AM before breakfast for all cases. it will be used as an objective indication of pain level. its normal values are 5 to 25 mcg/dl or 140-690 nmol/L.
8 weeks
Assessment of pain intensity
It will be assessed using the visual analogue scale (VAS). VAS is a simple and frequently used method for the assessment of variations in intensity of pain. In clinical practice the percentage of pain relief, assessed by VAS, is often considered as a measure of the efficacy of treatment. the scale ranges from 0 to 10 with 0 meaning no pain and 10 meaning severe pain
8 weeks
Study Arms (2)
Progressive muscle relaxation group
ACTIVE COMPARATORAll participants in this group will receive progressive muscle relaxation for 8 weeks
Progressive muscle relaxation and Yoga group
EXPERIMENTALAll participants in this group will receive the same progressive muscle relaxation plus yoga for 8 weeks.
Interventions
The participants will receive progressive muscle relaxation for 8 weeks. The muscles of the hand, arm, face, shoulder and neck, chest, abdomen, back, thigh and hip, legs and feet will be contracted and relaxed in sequence. The contraction time is 5 seconds (s), and the relaxation time is 10s.
The participants will receive yoga for 30 minutes/session, 3 sessions/week for 8 weeks. The session will begin with 5 minutes for warming up. Twenty minutes of wind relieving position (pavanmuktasana), corpse position (savasana), standing side stretch position, seated forward bend (paschimothanasana), cobra position (bhujangasana), and chair position (utkatasana). Five minutes of cooling down.
Eligibility Criteria
You may qualify if:
- Their ages will be ranged from 18 to 25 years old.
- Their body mass index (BMI) will be less than 30 kg/m².
- They will be virgin.
- They will have regular menstrual cycles.
- They will suffer from Premenstrual syndrome based on daily record of severity of problems.
- All women will be conscious and free from any medical disease.
You may not qualify if:
- Women with the following criteria should be excluded from this study:
- Women with endocrine disturbance.
- Endometriosis.
- Pelvic inflammatory disease.
- Any pelvic pathology conditions.
- Women had hysterectomy or ovariectomy.
- Women use medications as contraceptive pills, pain relief drugs and antidepressant drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Arwa mohamed Abd El-Wahab
Cairo, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Hossam Al Din Kamel, Professor
Al-Azhar University
- STUDY CHAIR
khadyga Abdul Aziz, Professor
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
October 29, 2024
First Posted
October 30, 2024
Study Start
November 2, 2024
Primary Completion
June 15, 2025
Study Completion
June 30, 2025
Last Updated
July 15, 2025
Record last verified: 2024-10